Pembrolizumab plus lenvatinib for non-clear cell kidney cancer
Immunotherapy combinations are becoming the standard treatment for people with [...]
Immunotherapy combinations are becoming the standard treatment for people with [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
Updated results and further follow up from the CaboNivo study [...]
The COSMIC-313 study previously showed improved survival when combining cabozantinib [...]
The results from an extended follow-up of the phase 1b [...]
Non-clear cell kidney cancer is a group of different subtypes [...]
The phase 2 KEYNOTE-B61 study was presented at the recent [...]
Samra Turajlic, Medical Oncologist, Action Kidney Cancer trustee, and member [...]
The International Kidney Cancer Symposium (IKCS) 2021 took place in [...]
Renal medullary carcinoma (RMC) is an extremely rare and aggressive [...]